Mar 09,2022 C4 Therapeutics Announces FDA Orphan Drug Designation for CFT8634 for the Treatment of Soft Tissue Sarcoma read more >>
Feb 04,2022 Dewpoint Therapeutics Announces Completion of $150 Million Series C Financing read more >>
Jan 27,2022 Twist Bioscience Signs Collaboration with Artisan Bio to Engineer Next Generation Cell Therapeutics read more >>
Jan 18,2022 Dermaliq Therapeutics Signs USD 15 Million Series A Round to Advance Three Transformative Drug Therapies into the Clinics read more >>
Nov 30,2021 Expert Opinion on Investigational Drugs Publishes "An Evaluation of KBP-5074 in Advanced CKD with Uncontrolled Hypertension" read more >>